TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 22736448

Group type: EXPERIMENTAL
Intervention: Resin sealant, single placement
Number of subjects: 501

Group type: EXPERIMENTAL
Intervention: 5% NaF varnish, semi‐annual application
Number of subjects: 501

Group type: EXPERIMENTAL
Intervention: 38% silver diamine fluoride (SDF) solution, annual application
Number of subjects: 501

Group type: COMPARATOR
Intervention: Placebo control
Number of subjects: 501
Study: 19648706

Group type: EXPERIMENTAL
Intervention: BRAVE Program intervention
Number of subjects: 178

Group type: COMPARATOR
Intervention: Standard public school curriculum
Number of subjects: 178
Study: 17766015

Group type: EXPERIMENTAL
Intervention: Herpes zoster vaccine
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 15249261

Group type: EXPERIMENTAL
Intervention: Web-based online medical record (SPPARO software)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Control group (no access to online medical record)
Number of subjects: 107
Study: 11428472

Group type: EXPERIMENTAL
Intervention: Simvastatin (10 mg at bedtime, increased to 20 mg if necessary) with behavioral modification
Number of subjects: 80

Group type: COMPARATOR
Intervention: Behavioral modification alone (calorie control and daily walking for 30 minutes)
Number of subjects: 80
Study: 9876998

Group type: EXPERIMENTAL
Intervention: 200 mg oral administration of alpha-lipoic acid
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 600 mg oral administration of alpha-lipoic acid
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 200 mg intravenous administration of alpha-lipoic acid
Number of subjects: 12
Study: 7986557

Group type: EXPERIMENTAL
Intervention: Aspirin 300 mg daily
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 2786856

Group type: EXPERIMENTAL
Intervention: Erdosteine 900 mg/day for one month
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 31928551

Group type: EXPERIMENTAL
Intervention: Peer‐identified change agents (PICAs)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Management‐selected change agents (MSCAs)
Number of subjects: 2
Study: 30789633

Group type: EXPERIMENTAL
Intervention: Nivolumab plus ipilimumab
Number of subjects: 1096

Group type: COMPARATOR
Intervention: Sunitinib
Number of subjects: 1096
Study: 28275125

Group type: EXPERIMENTAL
Intervention: LNS-LNS group (women and children both received LNSs)
Number of subjects: 4011
Study: 26062124

Group type: EXPERIMENTAL
Intervention: Tumor-primed NK cells (TpNK) infusion
Number of subjects: 7
Study: 23897401

Group type: EXPERIMENTAL
Intervention: Coached EMS practice (2009)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Multiple EMS practices
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Single EMS practices
Number of subjects: 16

Group type: COMPARATOR
Intervention: Routine training (controls)
Number of subjects: 16
Study: 20215489

Group type: EXPERIMENTAL
Intervention: Moderate to Vigorous Physical Activity (MVPA)
Number of subjects: 380

Group type: EXPERIMENTAL
Intervention: Sedentary Behavior (SED)
Number of subjects: 380

Group type: EXPERIMENTAL
Intervention: Regular Class Time
Number of subjects: 380

Group type: EXPERIMENTAL
Intervention: Achieving PA Guidelines
Number of subjects: 380

Group type: EXPERIMENTAL
Intervention: Physical Education (PE)
Number of subjects: 380
Study: 19842721

Group type: EXPERIMENTAL
Intervention: Low-dose heparin (2000-U bolus + 500 U/h)
Number of subjects: 64

Group type: COMPARATOR
Intervention: High-dose heparin (3000-U bolus + 800 U/h)
Number of subjects: 64
Study: 17088511

Group type: EXPERIMENTAL
Intervention: Paraprofessional-delivered home-visiting intervention
Number of subjects: 53

Group type: COMPARATOR
Intervention: Breastfeeding education program (Control)
Number of subjects: 53
Study: 15516040

Group type: EXPERIMENTAL
Intervention: Glucerna SR
Number of subjects: 456

Group type: COMPARATOR
Intervention: Resource Suport
Number of subjects: 456
Study: 11894755

Group type: EXPERIMENTAL
Intervention: Olive oil enriched diet
Number of subjects: 60

Group type: COMPARATOR
Intervention: Saturated fat diet
Number of subjects: 60
Study: 9756679

Group type: EXPERIMENTAL
Intervention: Low-technology lead hazard reduction activities (cleaning and repainting window areas, educating caregivers)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low-technology lead hazard reduction activities
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (children with lesser hazards)
Number of subjects: 0
Study: 7851099

Group type: EXPERIMENTAL
Intervention: Community Treatment Teams (CTTs)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Intensive Case Management Teams (ICMTs)
Number of subjects: 60
Study: 2898320

Group type: EXPERIMENTAL
Intervention: 15 mg metaclazepam per day for 2 weeks
Number of subjects: 50

Group type: COMPARATOR
Intervention: 4 mg bromazepam per day for 2 weeks
Number of subjects: 50
Study: 29703031

Group type: EXPERIMENTAL
Intervention: Low-level laser therapy administered in the region of the parotid glands bilaterally and in the regions of the submandibular and sublingual glands
Number of subjects: 50
Study: 28222379

Group type: EXPERIMENTAL
Intervention: Metabolic syndrome (MetS)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: sORP >140mV
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: cORP <0.50μC
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Higher sORP values
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lower cORP values
Number of subjects: 0
Study: 25424454

Group type: EXPERIMENTAL
Intervention: 2 h 75 g OGTT using the IADPSG criteria
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: 3 h 100 g OGTT using the Carpenter‐Coustan criteria
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: 2 h 75 g OGTT or whichever test is recommended by their doctor
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Screening endorsed by physicians and nurse midwives
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Blinded randomized GDM screening trial
Number of subjects: 68
Study: 23190251

Group type: EXPERIMENTAL
Intervention: Hypnosis group receiving three 1-hour lessons in self-hypnosis with additional audiorecordings
Number of subjects: 1222

Group type: EXPERIMENTAL
Intervention: Relaxation group receiving three 1-hour lessons in various relaxation methods and mindfulness with audiorecordings
Number of subjects: 1222

Group type: COMPARATOR
Intervention: Usual care group receiving ordinary antenatal care only
Number of subjects: 1222
Study: 21593803

Group type: EXPERIMENTAL
Intervention: α-lipoic acid (ALA) 600 mg intravenously once daily for 2 weeks
Number of subjects: 22
Study: 18477783

Group type: EXPERIMENTAL
Intervention: Clopidogrel (300-mg loading dose followed by daily dose of 75 mg; n = 441)
Number of subjects: 877

Group type: COMPARATOR
Intervention: Placebo (n = 436)
Number of subjects: 877
Study: 16792608

Group type: EXPERIMENTAL
Intervention: Fibreoptic orotracheal intubation
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Fibreoptic nasotracheal intubation
Number of subjects: 60
Study: 15849922

Group type: EXPERIMENTAL
Intervention: Tinidazole
Number of subjects: 456

Group type: COMPARATOR
Intervention: Albendazole
Number of subjects: 456
Study: 12505224

Group type: EXPERIMENTAL
Intervention: Ezetimibe 10 mg plus simvastatin (pooled doses)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ezetimibe 10 mg plus simvastatin 10 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Simvastatin 80 mg alone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Coadministration of ezetimibe and simvastatin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ezetimibe plus simvastatin
Number of subjects: 0
Study: 9623929

Group type: EXPERIMENTAL
Intervention: Insecticide-treated bednets and curtains
Number of subjects: 0
Study: 7792558

Group type: EXPERIMENTAL
Intervention: Dopamine infusion
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Dopamine infusion with selective beta 1-blockade (Metoprolol)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Basal postoperative conditions
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Glucose and lactate uptake
Number of subjects: 22
Study: 2613867

Group type: EXPERIMENTAL
Intervention: Preinsemination interval (PII) ranging from 30 to 540 minutes
Number of subjects: 1474
Study: 11760

Group type: EXPERIMENTAL
Intervention: Very high dose fluphenazine decanoate (250 mg weekly)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Standard dose fluphenazine decanoate (12.5 mg weekly)
Number of subjects: 50
Study: 30583032

Group type: EXPERIMENTAL
Intervention: Vitamin D3
Number of subjects: 162

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 162
Study: 28574723

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Exercise (HIIE)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Moderate-Intensity Exercise (MIE)
Number of subjects: 12
Study: 25926252

Group type: EXPERIMENTAL
Intervention: 4-month pre-operative physical rehabilitation protocol
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (no physical rehabilitation)
Number of subjects: 50
Study: 23452681

Group type: EXPERIMENTAL
Intervention: Previous community treatments for trichotillomania
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Age progression in hairpulling behavior
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Gender differences in distress and impairment
Number of subjects: 62
Study: 21478660

Group type: EXPERIMENTAL
Intervention: Operative treatment (open reduction and internal fixation)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Nonoperative treatment (closed treatment)
Number of subjects: 60
Study: 18342398

Group type: EXPERIMENTAL
Intervention: High-dose Phe (10 g)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Low-dose Phe (5 g Phe and 5 g glucose)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control (10 g glucose)
Number of subjects: 32
Study: 16575237

Group type: EXPERIMENTAL
Intervention: Elimination of forced bathing
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Inexpensive, practical, and evidence-based alternatives to forced bathing
Number of subjects: 0
Study: 12614303

Group type: EXPERIMENTAL
Intervention: Esomeprazole, 40 mg once daily
Number of subjects: 5241

Group type: COMPARATOR
Intervention: Lansoprazole, 30 mg once daily
Number of subjects: 5241
Study: 11115698

Group type: EXPERIMENTAL
Intervention: DNA vaccine (1, 2, or 4 microg)
Number of subjects: 12
Study: 9081208

Group type: EXPERIMENTAL
Intervention: High-dose therapy (HDT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional chemotherapy (CC)
Number of subjects: 0
Study: 8441910

Group type: EXPERIMENTAL
Intervention: Furazolidone, 7.5 mg/kg/day
Number of subjects: 133

Group type: COMPARATOR
Intervention: Chloramphenicol, 75 mg/kg/day
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Furazolidone, 7.5 mg/kg/day (susceptible strains)
Number of subjects: 133

Group type: COMPARATOR
Intervention: Chloramphenicol, 75 mg/kg/day (susceptible strains)
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Furazolidone (susceptible but chloramphenicol-resistant strains)
Number of subjects: 133
Study: 30693609

Group type: EXPERIMENTAL
Intervention: Magnesium (250 mg) plus Vitamin E (400 IU)
Number of subjects: 57
Study: 29223349

Group type: EXPERIMENTAL
Intervention: Cerebellar cathodal tDCS (2-mA for 20 min)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Sham-tDCS
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Cerebellar anodal tDCS
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Cerebellar cathodal tDCS
Number of subjects: 24
Study: 27040668

Group type: EXPERIMENTAL
Intervention: Gabapentin (GBP) superadded to a pre-existing regime containing amitriptyline (AMP)
Number of subjects: 77
Study: 24178916

Group type: EXPERIMENTAL
Intervention: Bilateral priming with device-assisted mirror symmetrical bimanual movements before upper limb physiotherapy, every weekday for 4 weeks.
Number of subjects: 57

Group type: COMPARATOR
Intervention: Intermittent cutaneous electric stimulation of the paretic forearm before physiotherapy.
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Bilateral priming intervention
Number of subjects: 57
Study: 22962427

Group type: EXPERIMENTAL
Intervention: Continuous Positive Airway Pressure (CPAP) therapy for 3 months
Number of subjects: 59
Study: 20450501

Group type: EXPERIMENTAL
Intervention: Tubeless PCNL (Group-I)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Standard PCNL with nephrostomy tube (Group-II)
Number of subjects: 95
Study: 18556716

Group type: EXPERIMENTAL
Intervention: Paclitaxel-eluting TAXUS stent (PES)
Number of subjects: 396

Group type: COMPARATOR
Intervention: Vascular brachytherapy (VBT)
Number of subjects: 396
Study: 16022966

Group type: EXPERIMENTAL
Intervention: Metyrapone 750 mg x 2
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 12367545

Group type: EXPERIMENTAL
Intervention: Swanson silicone trapezium implant
Number of subjects: 26

Group type: COMPARATOR
Intervention: Tendon interposition arthroplasty (APL)
Number of subjects: 26
Study: 10355396

Group type: EXPERIMENTAL
Intervention: Oral dipyridamole
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (Control)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dipyridamole (in 5 patients)
Number of subjects: 0
Study: 7478865

Group type: EXPERIMENTAL
Intervention: Mechanical load applied to the jaw during speech (17% of trials)
Number of subjects: 12

Group type: COMPARATOR
Intervention: No mechanical load (control)
Number of subjects: 12
Study: 1661121

Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin (LMWH) given as a single predialysis bolus injection
Number of subjects: 70

Group type: COMPARATOR
Intervention: Standard heparin (SH) administered with a continuous infusion
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin (LMWH)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Standard heparin (SH)
Number of subjects: 70
Study: 6807125

Group type: EXPERIMENTAL
Intervention: Doxapram (1‐1.5 mg/kg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 30636084

Group type: EXPERIMENTAL
Intervention: Passive Ultrasonic Irrigation (PUI)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Sonic techniques and Conventional Syringe Irrigation (CSI)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: All groups with intracanal SF
Number of subjects: 160
Study: 28656922

Group type: EXPERIMENTAL
Intervention: Casein phosphopeptide‐amorphous calcium fluoride phosphate (CPP‐ACFP) applied daily for 4 min for 4 weeks
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Comparison between study and control groups
Number of subjects: 30
Study: 25125441

Group type: EXPERIMENTAL
Intervention: Electrical stimulation combined with repetitive task practice therapy
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sham electrical stimulation combined with repetitive task practice therapy
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 40
Study: 24475821

Group type: EXPERIMENTAL
Intervention: Cancellous bone reconstructions (CBR) and multiplanar reconstructions (MPRs)
Number of subjects: 156

Group type: COMPARATOR
Intervention: Multiplanar reconstructions (MPRs) alone
Number of subjects: 156
Study: 21503389

Group type: EXPERIMENTAL
Intervention: Resistance exercise with 50% of 1-RM (E50%)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Resistance exercise with 70% of 1-RM (E70%)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control (C)
Number of subjects: 15
Study: 19659463

Group type: EXPERIMENTAL
Intervention: Montelukast
Number of subjects: 58

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58
Study: 17288653

Group type: EXPERIMENTAL
Intervention: Videophone support
Number of subjects: 43

Group type: COMPARATOR
Intervention: Telephone support
Number of subjects: 43
Study: 15459834

Group type: EXPERIMENTAL
Intervention: Cycle ergometer test (cyclic muscle activity)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Treadmill test (concentric muscle activity)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Bench‐steptest (eccentric muscle activity)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Baseline urinary 19‐NA and 19‐NE concentrations
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Likert scale of muscle soreness
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Overall exercise mode (eccentric or concentric)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: International Olympic Committee threshold level for nandrolone metabolites
Number of subjects: 15
Study: 11895217

Group type: EXPERIMENTAL
Intervention: Digoxin (0.25 mg orally 4x/day for 3 days)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Enalapril (20 mg/day orally for 3 days)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Furosemide (20 mg i.v. as a bolus at -5 minutes)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: GHRH + Arginine (0.5 g/kg i.v. from 0 to +30 minutes)
Number of subjects: 12
Study: 10090447

Group type: EXPERIMENTAL
Intervention: Latanoprost once daily for the first ten days and dorzolamide three times daily for the second ten days (Group 1)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Dorzolamide three times daily for the first ten days and latanoprost once daily for the second ten days (Group 2)
Number of subjects: 30
Study: 8150527

Group type: EXPERIMENTAL
Intervention: 105AD7 immunization
Number of subjects: 13

Group type: COMPARATOR
Intervention: Unimmunized patients
Number of subjects: 13
Study: 2971619

Group type: EXPERIMENTAL
Intervention: 0.1 micrograms ANF/min
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 0.3 micrograms ANF/min
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 1.0 microgram ANF/min
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 31898728

Group type: EXPERIMENTAL
Intervention: Beta transcranial alternating current stimulation (tACS) at 20 Hz, 1 mA peak-to-peak
Number of subjects: 108

Group type: COMPARATOR
Intervention: Sham stimulation (control)
Number of subjects: 108
Study: 30658675

Group type: EXPERIMENTAL
Intervention: StresSOS online intervention
Number of subjects: 15000

Group type: EXPERIMENTAL
Intervention: StresSOS face-to-face intervention
Number of subjects: 15000

Group type: COMPARATOR
Intervention: Active online control condition
Number of subjects: 15000
Study: 28716997

Group type: EXPERIMENTAL
Intervention: Warwick Edinburgh Mental Wellbeing Scale (WEMWBS)
Number of subjects: 221

Group type: EXPERIMENTAL
Intervention: WEMWBS
Number of subjects: 221

Group type: EXPERIMENTAL
Intervention: Optimism
Number of subjects: 221

Group type: EXPERIMENTAL
Intervention: Hope
Number of subjects: 221
Study: 25216510

Group type: EXPERIMENTAL
Intervention: LX4211 75 mg once daily
Number of subjects: 299

Group type: EXPERIMENTAL
Intervention: LX4211 200 mg once daily
Number of subjects: 299

Group type: EXPERIMENTAL
Intervention: LX4211 200 mg twice daily
Number of subjects: 299

Group type: EXPERIMENTAL
Intervention: LX4211 400 mg once daily
Number of subjects: 299

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 299

Group type: EXPERIMENTAL
Intervention: LX4211
Number of subjects: 299
Study: 23474354

Group type: EXPERIMENTAL
Intervention: Behavioural risk reduction intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard care control group
Number of subjects: 0
Study: 21518939

Group type: EXPERIMENTAL
Intervention: Individual-focused health promotion intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: HIV/STD risk reduction intervention
Number of subjects: 0
Study: 18571795

Group type: EXPERIMENTAL
Intervention: Manual acupuncture at Taichong (LV3)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Manual acupuncture at Xingjian (LV2)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Manual acupuncture at Neiting (ST44)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Sham point on the dorsum of the left foot
Number of subjects: 10
Study: 16920892

Group type: EXPERIMENTAL
Intervention: Rivaroxaban
Number of subjects: 0

Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 0
Study: 15258478

Group type: EXPERIMENTAL
Intervention: TLC-CPAP (telephone-linked communications for CPAP) in addition to usual care, n = 15
Number of subjects: 30

Group type: COMPARATOR
Intervention: Usual care alone, n = 15
Number of subjects: 30
Study: 11695801

Group type: EXPERIMENTAL
Intervention: Hemiarthroplasty
Number of subjects: 32

Group type: COMPARATOR
Intervention: Internal fixation
Number of subjects: 32
Study: 9298509

Group type: EXPERIMENTAL
Intervention: Nicotine (0.003-0.012 mg/kg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Atropine (0.001-0.01 mg/kg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cigarette smoking (for human chronic tobacco smokers)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Saline control injections
Number of subjects: 0
Study: 7956382

Group type: EXPERIMENTAL
Intervention: TENS
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo TENS
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control treatments
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 45
Study: 3282261

Group type: EXPERIMENTAL
Intervention: Ioversol
Number of subjects: 80

Group type: COMPARATOR
Intervention: Sodium meglumine diatrizoate (control)
Number of subjects: 80
Study: 30324799

Group type: EXPERIMENTAL
Intervention: Resin infiltration (Icon, DMG, Hamburg, Germany)
Number of subjects: 20
Study: 28189289

Group type: EXPERIMENTAL
Intervention: Plan‐Study‐Do‐Act (PDSA)‐CQI
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: CQI Actions selected by facilities
Number of subjects: 8
Study: 27160224

Group type: EXPERIMENTAL
Intervention: (18)F-FDG PET/CT performed before and during treatment
Number of subjects: 55

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 55
Study: 23952107

Group type: EXPERIMENTAL
Intervention: Atraumatic Restorative Treatment (ART)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Conventional Technique (CT)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Atraumatic Restorative Treatment (ART) with hygienist
Number of subjects: 82
Study: 22075719

Group type: EXPERIMENTAL
Intervention: Alfredson's heel-drop exercise programme
Number of subjects: 58